2nd National Conference on Blood Disorders In Public Health
IMPORTANT!

The Conference of the Global Sickle Cell Disease Network

Abstract submission deadline is November 25, 2011
Abstract submissions for this conference can be emailed to Isaac Odame

The 2nd Meeting of the Worldwide Initiative on Social Studies on Hemoglobinopathies

Abstract submission deadline is November 25, 2011
Abstract submissions for this conference can be emailed to Scott Grosse

The 2nd National Conference on Blood Disorders In Public Health
Abstract Submission closed on Sunday, September 18, 2011, 11:59pm Pacific


CALL FOR ABSTRACTS

The Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention; the Maternal and Child Health Bureau, Health Resources and Services Administration; the Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute, National Institutes of Health; and Hemophilia of Georgia are pleased to announce the 2nd National Conference on Blood Disorders in Public Health.

The purpose of this conference is to further advance the public health context described during the 1st National Conference on Blood Disorders in Public Health (March 2010) and to promote the adoption and full integration of evidenced-based and evidenced-informed public health functions that are capable of promoting the health of and improving outcomes among people with a blood disorder.

We are pleased to announce that this conference is being held in conjunction with the Conference of the Global Sickle Cell Disease Network (scheduled for Thursday March 15, 2012) and the 2nd Meeting of the Worldwide Initiative on Social Studies on Hemoglobinopathies (WISSH - scheduled for Friday March 16, 2012).

Conference Theme

From Outcomes to Impact: Addressing translational blocks to improving the publicís health - Disseminating and improving the adoption of effective preventive measures and therapeutic interventions.

Conference Goals

The goals of the conference are to:
  • Present innovative public health strategies to minimize the occurrence and complications of blood disorders.
  • Showcase effective evidenced-based public health interventions designed to prevent and/or eliminate blood disorder-related health disparities.

Conference Objectives

The objectives of the conference are to:
  • Increase understanding of evidence-based approaches to public health interventions for blood disorders, including strategies for assessing need and evaluating program impact.
  • Provide an interactive forum for attendees to discuss important and emerging public health issues in blood disorders.
  • Strengthen communication and networking, including the creation of new linkages between groups representing communities and existing partnerships to share best practices and improve the health of blood disorder populations.
  • Highlight current research findings, issues, and trends with the potential to impact the health of blood disorder populations.
  • Extend the reach of innovative public health practices by highlighting model and exemplary efforts in surveillance, monitoring, research, health promotion, community engagement, and evaluation addressing challenges to the health of persons with blood disorders.

Who Should Attend

  • Public health practitioners and other public health professionals at federal, tribal, state, and local levels.
  • Medical professionals, health education and communication specialists, health informatics specialists, researchers, and policy makers.
  • International public health colleagues.
  • Advocacy and public health professional organizations and associations.
  • Private-sector leaders.

Tracks

The Conference Planning Committee invites you to submit abstracts to be considered for presentation at the conference. The committee encourages interested individuals or organizations to submit abstracts that address specific issues, approaches or strategies that contribute to the prevention of complications experienced by people with blood disorders. Priority preference will be given to abstracts that demonstrate the application of public health strategies to promote the health and/or improve outcomes of people with blood disorders.

    Partnership/Collaboration
    Abstracts describe the development, maintenance and evaluation of partnerships and collaborations. Give examples of what constitutes an effective partnership and/or collaborative effort. Discuss the achievements, challenges, and lessons learned concerning partnering and/or collaborating.

    Prevention
    Abstracts focus on activities which target those at high risk for experiencing complications.

    Policy and Legislation
    Abstracts describe policies developed and implemented to promote and/or improve the health of people with blood disorders.

    Epidemiology - Surveillance and Research
    Abstracts include strategies for the development and implementation of surveillance systems and measures of quality of care, research studies, and use of data to describe public health impact.

    Laboratory - Research and Technology
    Abstracts include laboratory related topics related to hemoglobinopathies, bleeding and clotting disorders including research and strategies for the development and implementation of laboratory technology related to the screening and diagnosis of blood disorders, including newborn screening.

    Communication, Media, and Technology
    Abstracts demonstrate effective approaches to raise awareness, improve health literacy, and reach priority populations as they relate to blood disorders.

    Public Health System Improvement
    Abstracts give examples of patient and provider practices and policies which improve the quality of care or improve outcomes of people with blood disorders.

    Disparities
    Abstracts demonstrate how to improve health disparities among racial and ethnic minority and rural populations through new and/or innovative approaches. Abstracts which demonstrate innovation and sustainability, which are deemed by reviewers to contribute substantively to an improved understanding or elucidation of the themes cited above, will receive special consideration and are more likely to be accepted.

Submisson Timeline

To be considered for the conference, all abstracts must be submitted according to the instructions below by Sunday, September 18, 2011. Late abstract submissions will not be accepted. We will not accept every abstract for presentation. If the abstract is accepted, the submitter will receive a request to confirm availability to attend the conference and make the presentation. Information will be included on the type of presentation format, date, and time in subsequent communications.

Evaluation Criteria

  • Presentations should relate to one or more of the abstract topics, meet the overall goals of the conference, and are of significant public health importance.
  • Purpose/objectives should be clear and well described.
  • Work should be performed using rigorous scientific methods (scientific/epidemiologic related submissions) or should have appropriate program planning and evaluation methods (programmatic submissions).
  • Results or outcomes should be described in the abstract and be relevant to conference participants.

Submission Method

Abstracts must be submitted electronically through the conference Web site no later than Sunday, September 18, 2011. An E-mail confirming receipt will be sent to the submitter immediately. For submission questions contact Keshia Jones-Johnson.

Confirmation

We will notify abstract submitters of their acceptance status by Monday, October 31, 2011. There will be a strict review process of all abstracts received. We will not accept every abstract for presentation. If the abstract is accepted, the submitter will receive a request to confirm availability to attend the conference and make the presentation. The correspondence will also include information about presentation format, date, and time. Submitters are responsible for responding to all notices sent by the conference contractor on behalf of the abstracts.

Presenterís Responsibilities

  • Handouts are strongly encouraged for all conference presentations.
  • PowerPoint presentations should be sent to the conference contractor prior to the conference.
  • Following the conference, the PowerPoint presentations will be posted online.
  • Presenters are responsible for all expenses related to participating in the conference, including transportation, registration fee, lodging, and meals. However in extreme cases where financial support cannot be obtained limited travel funding is available to support speakers. The deadline for submitting requests for travel support is October 30, 2011. Interested persons should contact Chris Parker.

Presentation Options

Three options are available for presentations. The options are:
  1. Oral presentation during concurrent breakout sessions (15-minute presentation and 5 minutes for questions and answers) (one presenter per abstract)
  2. Poster presentation
  3. Special Session Proposal includes 1-3 oral presentations during a proposed 1-hour special session (see below)

Instructions for SUBMITTING ORAL OR POSTER ABSTRACTS

Oral Presenters will be allowed 15 minutes to speak and 5 minutes to take questions from the audience; poster session presenters are expected to be available to discuss their poster with conference participants during their respective poster session.

General considerations:

  • All abstracts must be in English.
  • Only online submissions will be considered.
  • Abstracts should describe original work.
  • Authors should identify a specific track for which their abstract may be most appropriate (see the lists above).
  • If submitting more than one abstract, please submit them separately. Please do not include any names in the body of the abstract.
  • Authors are strongly encouraged to compose the abstract text in your own word processor before submitting it online. Be sure to check spelling, word count, and conformance with the guidelines provided in this document.
  • Use plain text only. Do not use italics, diagrams, boxes, borders, or tables. No graphics are permitted.
  • All abbreviations and acronyms must be spelled out when first used. Section headings are not counted in word or character totals.
  • Abstract titles should not exceed 15 words.
  • Abstract text must not exceed 350 words in length.
  • All abstract text must conform to a structured format, including each of the following headings (enter n/a for any sections which are not applicable).
    • Background
    • Objectives
    • Methods
    • Results
    • Conclusion and implications for public health practice
  • Along with the contact information, abstract presenters are required to submit the following: These items are not included in the 350 word limit.

Instructions for SUBMITTING PROPOSALS FOR SPECIAL SESSIONS

The committee is also inviting submissions of proposals for special sessions. These sessions are expected to be one hour long and include 1 to 3 presentations on a subject of interest (no more than 45 minutes of presentations Ė the committee would like to make sure there is enough time for discussion). If not accepted for a special session, authors may be invited to make an individual oral or poster presentation.

General considerations:

  • All submissions must be in English.
  • Only online submissions will be considered.
  • Submissions should describe original work.
  • Authors should identify a specific track for which their submission may be most appropriate (see the lists above).
  • If submitting more than one abstract, please submit them separately. Please do not include any names in the body of the abstract.
  • Authors are strongly encouraged to compose the abstract text in your own word processor before submitting it online. Be sure to check spelling, word count, and conformance with the guidelines provided in this document.
  • All abbreviations and acronyms must be spelled out when first used. Section headings are not counted in word or character totals.
  • Submission titles should not exceed 15 words.
  • Abstract text must not exceed 1000 words or 750 words plus one graph or table.
  • One presentaion is required for each special session. If the session will include more than one presenter, please list all presentations, not to exceed 3 presentations.
  • Abstract text for each submission must conform to a structured format, including each of the following headings (enter n/a for any sections which are not applicable).
    • Background
    • Objectives
    • Methods
    • Results
    • Conclusion and implications for public health practice
  • Along with the contact information, session presenters are required to submit the following: These items are not included in the 350 word limit.


If you already submitted an abstract title and you wish to view, resume, edit, or withdraw that submission, log-in below using the access codes already provided to you.

Returning Paper/Poster Submitters:
Abstract ID#      Password 

Returning Special Session Submitters:

Abstract ID#      Password 

Technical support may be obtained by calling (401) 334-0220 between 8:30 a.m and 6:00 p.m. Eastern Time, Monday-Friday, or at all times by contacting tech support.

YOU DO NOT NEED AN ID OR PASSWORD TO SUBMIT AN ABSTRACT FOR THE FIRST TIME. TO BEGIN, READ THE GUIDELINES, THEN CLICK THE APPROPRIATE BUTTON ABOVE.

Technical support may be obtained by calling 401-334-0220 between 8:30 am-6 pm EDT, Monday-Friday.